D 01 (Zidovudine 100 mg)
Pill imprint D 01 has been identified as Zidovudine 100 mg.
Zidovudine is used in the treatment of reduction of perinatal transmission of hiv; nonoccupational exposure; occupational exposure; hiv infection and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Zidovudine 100 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for D 01
- 100 mg
- Prescription only
- Drug Class:
- Nucleoside reverse transcriptase inhibitors (NRTIs)
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Aurobindo Pharma
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
sodium starch glycolate type A potato
sodium lauryl sulfate
|NDC Code||Manufacturer / Repackager|
|68084-0461||Amerisource Health Services|
Note: Inactive ingredients may vary.
More about zidovudine
- Zidovudine capsules
- Zidovudine syrup
- Zidovudine injection
- Zidovudine (Advanced Reading)
- Zidovudine Intravenous (Advanced Reading)
- Other brands: Retrovir
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.